11-12-2023, 20:00

AiViva Biopharma Completes Phase 1/2 Clinical Trial of AIV001 Administration in Patients with Nonmelanoma Skin Cancer
Globe Newswire11-12-2023, 20:00
31-10-2023, 18:00

Cambrium Secures €8 Million in Seed Funding to Commercialize New Class of Performance Molecules
Globe Newswire31-10-2023, 18:00
18-09-2023, 17:00

AiViva Biopharma Appoints Lester J. Kaplan, PhD to the Board of Directors
Globe Newswire18-09-2023, 17:00
6-06-2023, 14:00

Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023
Globe Newswire6-06-2023, 14:00
23-05-2023, 20:00

Telesis Bio to Present at SynBioBeta 2023
Globe Newswire23-05-2023, 20:00
22-05-2023, 23:00

Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning Kit
Globe Newswire22-05-2023, 23:00
16-05-2023, 08:00

Global talent leader WilsonHCG announces integration of Profile and Personify brands 
Globe Newswire16-05-2023, 08:00
23-03-2023, 18:00

Cambrium Launches NovaColl™: First Micro-Molecular & Skin-Identical Collagen Ingredient for Personal Care Industry
Globe Newswire23-03-2023, 18:00
16-03-2023, 16:04

Medigene to present first pre-clinical data for MDG1015

Martinsried/Munich, March 16, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an early stage immuno-oncology
Globe Newswire16-03-2023, 16:04
9-03-2023, 22:25

2023 SXSW Conference Hosts Psychedelic Healthcare VC Fund

CHICAGO and NEW YORK, March 09, 2023 (GLOBE NEWSWIRE) -- As therapeutic applications of psychedelics gain more
Globe Newswire9-03-2023, 22:25
8-03-2023, 01:02

LanzaTech (LNZA) Announces New Board Members to Accelerate

New directors bring diverse wealth of experience across sustainable development, corporate finance, and social impact
Globe Newswire8-03-2023, 01:02
28-02-2023, 07:27

Alvotech Announces Webcast of 2022 Full Year Financial

Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar
Globe Newswire28-02-2023, 07:27